PROTAC BTK Degrader-13
PROTAC BTK Degrader-13 (Compound 25) is the PROTAC degrader for BTK with a DC50 of 0.27 μM. PROTAC BTK Degrader-13 inhibits the activity of BTK with an IC50 of 0.44 μM, inhibits IL-2-induced T cell kinase (ITK) with an IC50 of 2.16 μM. PROTAC BTK Degrader-13 inhibits p38 MAPK signaling pathway, block the activation of the BCR (B cell receptor) signaling pathway[1]. (Pink: ligand for target protein BTK ligand 15 ; Black: linker (HY-Y0524) ; Blue: ligand for E3 ligase cereblon (HY-103596) )
Product Specifications
UNSPSC
12352211
Target
Btk; Itk; p38 MAPK; PROTACs
Related Pathways
MAPK/ERK Pathway; PROTAC; Protein Tyrosine Kinase/RTK
Field of Research
Cancer; Inflammation/Immunology
Smiles
O=C1NC2=NC=C(C3=CC=C(OCO4)C4=C3)C=C2C15CCN(CCNC6=C7C(C(N(C8C(NC(CC8)=O)=O)C7=O)=O)=CC=C6)CC5
Molecular Formula
C33H30N6O7
Molecular Weight
622.63
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Sertad3-set siRNA/shRNA/RNAi Lentivector (Mouse)
AGO4 (Protein Argonaute-4, Argonaute4, hAgo4, Eukaryotic Translation Initiation Factor 2C 4, eIF-2C 4, eIF2C 4, EIF2C4, AGO4, KIAA1567) (MaxLight 490)